Pharmaceutical Executive
Guidelines on how innovators can assert patents to protect their products’ exclusivity while avoiding claims from competitors and the FTC that their conduct runs afoul of U.S. antitrust law.
Tony Pezzano
Advertisement
Articles by Tony Pezzano
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on PharmExec
1
Beyond Amyloid, Part One (of two): Tau and Microglia Redefine the Alzheimer’s Pipeline
2
What the Peptide Advisory Vote Actually Means: Q&A with James LaValle
3
M&A Roundup: IntraGel & UroGen Sign Collaboration & Investment Agreements, Lupin & Tenpoint Form Commercialization Collaboration
4
Hanmi Pharm Enters $2.3 Billion Licensing Agreement with Genentech for HM17321
5